SanofiFR0000120578SANSAN
![Sanofi logo](https://static.getquin.com/logos_v2/light/FR0000120578.png)
Financials
Market Cap
$148.05B5Y beta
0.46EPS (TTM)
$3.711Free Float
1.10BP/E ratio (TTM)
31.45Revenue (TTM)
$52.30BEBITDA (TTM)
$15.46BPricing
Analyst Ratings
The price target is $117.68 and the stock is covered by 26 analysts.
Buy
20
Hold
5
Sell
1
Information
Sanofi SA is a France-based healthcare company based in France. The Company focuses on patient needs and engages in the research, development, manufacture, and marketing of therapeutic solutions. Its three operating segments are: Pharmaceuticals, Consumer Healthcare (CHC), and Vaccines. The Pharmaceuticals includes: Immunology, Multiple Sclerosis / Neurology, Oncology, Rare Diseases, Rare Blood Disorders, Cardiovascular, Diabetes, Established Prescription Products. The Vaccines segment comprises, for all geographical territories, the commercial operations of Sanofi Pasteur, together with research, development, and production activities dedicated to vaccines. The CHC segment comprises the commercial operations for Sanofi’s Consumer Healthcare products, together with research, development and production activities dedicated to those products. The Company’s products developed in collaboration or franchise include Dupixent, Aubagio, Lemtrada, Cerezyme, Lumizyme, Jevtana, Fabrazyme.